Woźniak, M.; Pastuch-Gawołek, G.; Makuch, S.; Wiśniewski, J.; Krenács, T.; Hamar, P.; Gamian, A.; Szeja, W.; Szkudlarek, D.; Krawczyk, M.;
et al. In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment. Int. J. Mol. Sci. 2021, 22, 1748.
https://doi.org/10.3390/ijms22041748
AMA Style
Woźniak M, Pastuch-Gawołek G, Makuch S, Wiśniewski J, Krenács T, Hamar P, Gamian A, Szeja W, Szkudlarek D, Krawczyk M,
et al. In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment. International Journal of Molecular Sciences. 2021; 22(4):1748.
https://doi.org/10.3390/ijms22041748
Chicago/Turabian Style
Woźniak, Marta, Gabriela Pastuch-Gawołek, Sebastian Makuch, Jerzy Wiśniewski, Tibor Krenács, Peter Hamar, Andrzej Gamian, Wiesław Szeja, Danuta Szkudlarek, Monika Krawczyk,
and et al. 2021. "In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment" International Journal of Molecular Sciences 22, no. 4: 1748.
https://doi.org/10.3390/ijms22041748
APA Style
Woźniak, M., Pastuch-Gawołek, G., Makuch, S., Wiśniewski, J., Krenács, T., Hamar, P., Gamian, A., Szeja, W., Szkudlarek, D., Krawczyk, M., & Agrawal, S.
(2021). In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment. International Journal of Molecular Sciences, 22(4), 1748.
https://doi.org/10.3390/ijms22041748